Emese Kiss

Best Publications

• Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D?

  H. Amital;Z. Szekanecz;G. Szücs;K. Dankó

  389
  Citations

• Current causes of death in systemic lupus erythematosus in Europe, 2000--2004: relation to disease activity and damage accrual.

  Johannes C. Nossent;N. Cikes;E. Kiss;A. Marchesoni

  326
  Citations

• Association of systemic and thyroid autoimmune diseases.

  Edit Biró;Zoltán Szekanecz;László Czirják;Katalin Dankó

  282
  Citations

• Five-year follow-up of 665 Hungarian patients with undifferentiated connective tissue disease (UCTD).

  Edit Bodolay;Zoltan Csiki;Zoltan Szekanecz;Thomas Ben

  205
  Citations

• Disease activity and damage accrual during the early disease course in a multinational inception cohort of patients with systemic lupus erythematosus.

  J Nossent;E Kiss;B Rozman;G Pokorny

  196
  Citations

• Heat shock protein 70 is a potent activator of the human complement system.

  Zoltán Prohászka;Mahavir Singh;Kálmán Nagy;Emese Kiss

  161
  Citations

• Anti-vitamin D, vitamin D in SLE: preliminary results.

  Jozélio Freire Carvalho;Jozélio Freire Carvalho;Miri Blank;Emese Kiss;Tunde Tarr

  155
  Citations

• Comparative assessment of vascular function in autoimmune rheumatic diseases: considerations of prevention and treatment.

  Pál Soltész;György Kerekes;Henriett Dér;Gabriella Szücs

  155
  Citations

• Cardiac manifestations in antiphospholipid syndrome

  Pál Soltész;Zoltán Szekanecz;Emese Kiss;Yehuda Shoenfeld

  147
  Citations

• Systemic lupus erythematosus: clinical features in patients with a disease duration of over 10 years, first evaluation

  A. J. G. Swaak;H. G. van den Brink;R. J. T. Smeenk;K. Manger

  140
  Citations

• Incomplete lupus erythematosus: results of a multicentre study under the supervision of the EULAR Standing Committee on International Clinical Studies Including Therapeutic Trials (ESCISIT)

  A. J. G. Swaak;H. van de Brink;R. J. T. Smeenk;K. Manger

  133
  Citations

• Dyslipidemia in systemic lupus erythematosus

  Melinda Zsuzsanna Szabó;Peter Szodoray;Emese Kiss

  131
  Citations

• Isotype distribution and clinical relevance of anti‐β2‐glycoprotein I (β2‐GPI) antibodies: importance of IgA isotype

  Gabriella Lakos;E. Kiss;N. Regéczy;P. Tarján

  121
  Citations

• Malignancies in systemic lupus erythematosus

  Emese Kiss;Laszlo Kovacs;Peter Szodoray

  112
  Citations

• Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients

  T. Tarr;G. Lakos;H. P. Bhattoa;Y. Shoenfeld

  112
  Citations

• The immunopathological role of vitamin D in patients with SLE: data from a single centre registry in Hungary.

  P Szodoray;T Tarr;A Bazso;G Poor

  110
  Citations

• Reduced flow-mediated vasodilation as a marker for cardiovascular complications in lupus patients.

  Emese Kiss;Pal Soltesz;Henrietta Der;Zsolt Kocsis

  109
  Citations

• Malignancies and soluble tumor antigens in rheumatic diseases.

  Éva Szekanecz;Csilla András;Zsuzsa Sándor;Péter Antal-Szalmás

  108
  Citations

• Evaluation of clinical and laboratory features of antiphospholipid syndrome: a retrospective study of 637 patients.

  P Soltész;K Veres;G Lakos;E Kiss

  108
  Citations

• Antibodies against human heat-shock protein (hsp) 60 and mycobacterial hsp65 differ in their antigen specificity and complement-activating ability

  Zoltán Prohászka;Jenõ Duba;Gabriella Lakos;Emese Kiss

  102
  Citations

• Measurement of natural (CD4+CD25high) and inducible (CD4+IL-10+) regulatory T cells in patients with systemic lupus erythematosus:

  S. Barath;M. Aleksza;T. Tarr;S. Sipka

  92
  Citations

• Systemic lupus erythematosus. Disease outcome in patients with a disease duration of at least 10 years: second evaluation.

  Ajg J.G. Swaak;H. G. Van Den Brink;Rjt J.T. Smeenk;K. Manger

  86
  Citations

• Significant correlation between the CD63 assay and the histamine release assay in chronic urticaria

  A. Szegedi;B. Irinyi;M. Gál;J. Hunyadi

  85
  Citations